Relationships between cholesterol homoeostasis and triacylglycerol-rich lipoprotein remnant metabolism in the metabolic syndrome

Clinical Science

Volumn 104, Issue 4, 2003, Pages 383-388

  Chan, Dick C ^a   Watts, Gerald F ^a   Barrett, P Hugh R ^a   O'Neill, Frans H ^b   Redgrave, Trevor G ^c   Thompson, Gilbert R ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breath test; Campesterol; Cholesterol absorption; Chylomicron remnant metabolism; Dyslipidaemia

Indexed keywords

APOLIPOPROTEIN B48; BIOLOGICAL MARKER; CAMPESTEROL; CHOLESTEROL; LATHOSTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ABSORPTION; ADULT; ARTICLE; CATABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; EMULSION; HOMEOSTASIS; HUMAN; LIPID ANALYSIS; LIPID METABOLISM; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

APOLIPOPROTEIN B-48; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BREATH TESTS; CASE-CONTROL STUDIES; CHOLESTEROL; HUMANS; LINEAR MODELS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYTOSTEROLS; TRIGLYCERIDES;

EID: 0037394601     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20020298     Document Type: Article

References (33)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J. Am. Med. Assoc. 285, 2486-2497
2. Hodis, H. N. and Mack, W. J. (1995) Triglyceride-rich lipoproteins and the progression of coronary artery disease. Curr. Opin. Lipidol. 6, 209-214
3. Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T. and Hamsten, A. (1993) Metabolism of triglyceride-rich lipoprotein during alimentary lipidemia. J. Clin. Invest. 91, 748-758
4. Thompson, G. R., Naoumova, R. and Watts, G. F. (1996) Role of cholesterol in regulating apolipoprotein B secretion by the liver. J. Lipid Res. 37, 439-447
5. Miettinen, T. A., Tilvis, R. S. and Kesaniemi, Y. A. (1990) Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am. J. Epidemiol. 131, 20-31
6. Simonen, P. P., Gylling, H. and Miettinen, T. A. (2002) Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics. Obes. Res. 10, 328-335
7. Leary, E. T., Wang, T., Baker, D. J. et al. (1998) Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma. Clin. Chem. 44, 2490-2498
8. Smith, D., Watts, G. F., Dane-Stewart, C. A. and Mamo, J. C. L. (1999) Postprandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B-48 in the fasting state. Eur. J. Clin. Invest. 29, 204-209
9. 2 breath test to assess the metabolism of triglyceride-rich lipoprotein remnants in mice. J. Lipid Res. 39, 691-698
10. Redgrave, T. G., Watts, G. F., Martins, I. J. et al. (2001) Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test. J. Lipid Res. 42, 710-715
11. Nakajima, K., Saito, T., Tamura, A. et al. (1993) Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti-apoB-100 and anti-apoA-I immunoaffinity mixed gels. Clin. Chim. Acta 223, 53-71
12. Smith, D., Proctor, S. D. and Mamo, J. C. L. (1997) A highly sensitive assay for quantitation of apolipoprotein B-48 using an antibody to human apolipoprotein B and enhanced chemiluminescence. Ann. Clin. Biochem. 34, 185-189
13. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419
14. Hixson, J. E. and Vernier, D. T. (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31, 545-548
15. Miettinen, T. A. (1988) Cholesterol metabolism during ketoconazole treatment in man. J. Lipid Res. 29, 43-51
16. Plat, J. and Mensink, R. P. (2001) Effects of diets enriched with two different plant stand ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 50, 520-529
17. Watts, G. F., Chan, D. C., Barrett, P. H., Martins, I. J. and Redgrave, T. G. (2001) Preliminary experience with a new stable isotope breath test for chylomicron remnant metabolism: a study in central obesity. Clin. Sci. 101, 683-690
18. Miettinen, T. A. and Gylling, H. (2000) Cholesterol absorption efficiency and sterol metabolism in obesity. Atherosclerosis 153, 241-248
19. Simonen, P. P., Gylling, H., Howard, A. N. and Miettinen, T. A. (2000) Introducing a new component of the metabolic syndrome: low cholesterol absorption. Am. J. Clin. Nutr. 72, 82-88
20. Ostlund, R. E., Bosner, M. S. and Stenson, W. F. (1999) Cholesterol absorption efficiency declines at moderate dietary doses in normal human subjects. J. Lipid Res. 40, 1453-1458
21. Watts, G. F., Chan, D. C., Barrett, P. H. R., O'Neill, F. H. and Thompson, G. R. (2002) Effects of a HMG CoA reductase inhibitor on cholesterol absorption in obesity: implications for the regulation of very-low-density lipoprotein B-100 metabolism. Atherosclerosis 3 (Suppl.), 235
22. Lindenthal, B., Sudhop, T., Schiedermaier, P., Agnan, M., Sauerbruch, T. and von Bergmann, K. (2002) Serum plant sterols and biliary cholesterol secretion in humans: studies with ursodeoxycholic acid. J. Lipid Res. 43, 1072-1077
23. Hirany, S., O'Byrne, D., Devaraj, S. and Jialal, I. (2000) Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease. Clin. Chem. 46, 667-672
24. Takahashi, H., Hashimoto, N., Kawasaki, T., Kikuchi, T. and Uchiyama, M. (1996) The usefulness of measuring body fat deposition for detecting obesity and atherogenesity in Japanese school children. Acta Paediatr. Jpn. 38, 634-649
25. Mekki, N., Christofilis, M. A., Charbonnier, M. et al. (1999) Influence of obesity and body fat distribution on postprandial lipemia and triglyceride-rich lipoproteins in adult women. J. Clin. Endocrinol. Metab. 84, 184-191
26. Mamo, J. C. L., Watts, G. F., Barrett, P. H. R., Smith, D., James, A. P. and Pal, S. (2001) Postprandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression? Am. J. Physiol. Endocrinol. Metab. 281, E626-E632
27. Despres, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A. and Bouchard, C. (1990) Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Atherosclerosis 10, 497-511
28. Mazzone, T., Foster, D. and Chait, A. (1984) In vivo stimulation of low-density lipoprotein degradation by insulin. Diabetes 33, 333-338
29. Watts, G. F., Cummings, M. H., Kelly, J. M., Umpleby, A. M., O'Brien, S. F. and Sonksen, P. H. (1996) Acute hyperinsulinaemia decreases hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in normolipidaemic, non-diabetic subjects. Endocrinol. Metab. 3, 253-263
30. Cooper, A. D. (1997) Hepatic uptake of chylomicron remnants. J. Lipid Res. 38, 2173-2192
31. Chan, D. C., Watts, G. F., Redgrave, T. G., Mori, T. A. and Barrett, P. H. R. (2002) Apolipoprotein B-100 kinetics in visceral obesity: associations with plasma apolipoprotein C-III concentration. Metabolism 51, 1041-1046
32. Horton, J. D., Goldstein, J. L. and Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131
33. Berge, K. E., von Bergmann, K., Lutjohann, D. et al. (2002) Heritability of plasma noncholesterol sterols and relationship to DNA sequence polymorphism in ABCG5 and ABCG8. J. Lipid Res. 43, 486-494